Myung In Pharmaceutical LTD. (KRX:317450)
South Korea · Delayed Price · Currency is KRW 104,200
-5,500 (-5.01%)
At close: Oct 15, 2025
KRX:317450 Revenue
Myung In Pharmaceutical LTD. had revenue of 71.23B KRW in the quarter ending June 30, 2025. This brings the company's revenue in the last twelve months to 280.62B. In the year 2024, Myung In Pharmaceutical LTD. had annual revenue of 269.43B with 11.18% growth.
Revenue (ttm)
280.62B
Revenue Growth
+11.18%
P/S Ratio
5.42
Revenue / Employee
837.66M
Employees
335
Market Cap
1,521.32B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 269.43B | 27.10B | 11.18% |
| Dec 31, 2023 | 242.34B | 16.51B | 7.31% |
| Dec 31, 2022 | 225.83B | 16.58B | 7.92% |
| Dec 31, 2021 | 209.25B | 21.41B | 11.40% |
| Dec 31, 2020 | 187.84B | 6.05B | 3.33% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 308.59T |
| SK hynix | 77.21T |
| LG Energy Solution | 25.16T |
| Samsung Biologics | 5,031.69B |
| Hyundai Motor Company | 182.25T |
| Doosan Enerbility | 16.30T |
| Hanwha Aerospace | 19.25T |
| HD Hyundai Heavy Industries | 15.58T |